Scientists developed 3D-printed living skin with blood vessels

Scientists in the US have created 3D-printed skin complete with blood vessels, an advancement which they hope could be a significant step toward creating grafts that are more like the skin our bodies naturally produce.

The team of researchers at Rensselaer Polytechnic Institute in New York and Yale School of Medicine combined cells found in human blood vessels with other ingredients, including animal collagen, and printed a skin-like material.

After a few weeks, the cells started to form into vasculature (the arrangement of blood vessels in an organ or part), after which the skin was transplanted onto a mouse. Following this procedure, the team found the skin connected with the animal’s vessels.

In their latest study, the researchers demonstrated that if they add key elements – including human endothelial cells, which line the inside of blood vessels, and human pericyte cells, which wrap around the endothelial cells – with animal collagen and other structural cells typically found in a skin graft, the cells start communicating and forming a biologically relevant vascular structure within the span of a few weeks.

As engineers working to recreate biology, we’ve always appreciated and been aware of the fact that biology is far more complex than the simple systems we make in the lab.

“We were pleasantly surprised to find that, once we start approaching that complexity, biology takes over and starts getting closer and closer to what exists in nature.”

Once the Yale team grafted it onto a special type of mouse, the vessels from the skin printed by the Rensselaer team began to communicate and connect with the mouse’s own vessels.

“That’s extremely important because we know there is actually a transfer of blood and nutrients to the graft which is keeping the graft alive,” Karande added.

In order to make this process usable at a clinical level, however, the researchers would need to be able to edit the donor cells using CRISPR (gene editing) technology to ensure that the vessels can integrate and be accepted by the patient’s body.

“This significant development highlights the vast potential of 3D bioprinting in precision medicine, where solutions can be tailored to specific situations and eventually to individuals,” said Deepak Vashishth, the director of CBIS. “This is a perfect example of how engineers at Rensselaer are solving challenges related to human health.”

Subscribe for updates

Accredited By UKAF Limited for Quality and Environmental Management Systems, United Kingdom

Copyright © 2021 FORCYST ENGINEERING LLP. All rights reserved. 

  • LinkedIn Social Icon
  • Facebook Social Icon